Immutep

IMMP · ASX

$3.20+$0.03 (+0.95%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $3.17

Latest news

Press releaseOct 23, 8:00 AM ETGlobe Newswire
Immutep Announces Presentation of Quality of Life Data from EFTISARC-NEO Phase II Trial at ESMO 2026
Press releaseOct 19, 8:00 AM ETGlobe Newswire
Immutep Announces Late-Breaking Abstract on IMP761 Accepted for Poster Presentation at ACR Convergence 2026
Press releaseOct 13, 8:00 AM ETGlobe Newswire
Immutep Regains Compliance with Nasdaq Minimum Bid Price Requirement
Press releaseSep 30, 8:00 AM ETGlobe Newswire
Immutep Receives ~A$0.86 Million R&D Tax Incentive
Press releaseSep 21, 8:00 AM ETGlobe Newswire
Change to American Depositary Share Ratio
Press releaseSep 11, 8:00 AM ETGlobe Newswire
Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)
Press releaseJul 24, 8:00 AM ETGlobe Newswire
Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026
Press releaseJul 14, 8:00 AM ETGlobe Newswire
Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor
Press releaseJul 13, 8:00 AM ETGlobe Newswire
Immutep Provides Clinical Update in 1st line NSCLC: Positive Mature Overall Survival Data from INSIGHT-003 and Update from TACTI-004
Press releaseJun 30, 4:31 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines – IMMP
Press releaseJun 29, 7:27 PM ETNewsfile
Robbins LLP Urges IMMP Stockholders to Move for Lead Plaintiff Before the July 6, 2026 Deadline
Press releaseJun 16, 4:16 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines – IMMP
Press releaseJun 16, 10:56 AM ETGlobe Newswire
Portnoy Law Firm Announces Class Action on Behalf of Immutep Limited Investors
Press releaseJun 11, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines - IMMP
Press releaseJun 10, 9:00 AM ETPRNewswire
IMMP Deadline Alert: Levi & Korsinsky Reminds Immutep Limited (IMMP) Investors of Securities Class Action Deadline on July 6, 2026
Press releaseJun 9, 9:06 PM ETPRNewswire
IMMP Investor Alert - Immutep Limited Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit
Press releaseJun 5, 1:57 PM ETGlobe Newswire
Robbins LLP Reminds IMMP Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Immutep Limited
Press releaseJun 4, 5:33 PM ETPRNewswire
IMMP Shareholder Alert: Immutep Limited Securities Class Action Lawsuit - Investors Should Contact SueWallSt
Press releaseJun 4, 10:00 AM ETPRNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines - IMMP
Press releaseJun 3, 9:00 AM ETPRNewswire
IMMP DEADLINE: Levi & Korsinsky Reminds Immutep Limited Investors of Upcoming Securities Class Action Deadline
Press releaseJun 3, 3:02 AM ETPRNewswire
Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP
Press releaseJun 2, 4:32 PM ETGlobe Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines – IMMP
Press releaseJun 2, 4:00 PM ETBusiness Wire
IMMP Shareholder Alert: Immutep Limited Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
Press releaseJun 2, 9:00 AM ETPRNewswire
IMMP Shareholder Alert: Immutep Limited Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm
Press releaseJun 1, 3:58 AM ETPRNewswire
IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm
Press releaseMay 29, 9:00 AM ETGlobe Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 6, 2026 in Immutep Limited Lawsuit - IMMP
Press releaseMay 28, 9:00 AM ETPRNewswire
SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026 - IMMP
Press releaseMay 27, 9:00 AM ETPRNewswire
IMMP Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Immutep Limited Securities Lawsuit - Contact Levi & Korsinsky
Press releaseMay 26, 9:00 AM ETBusiness Wire
Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights
Press releaseMay 26, 9:00 AM ETPRNewswire
IMMP Shareholder Alert: July 6, 2026 Lead Plaintiff Deadline in Immutep Limited Securities Class Action - Contact The Gross Law Firm
Press releaseMay 21, 9:00 AM ETPRNewswire
Lost Money on Immutep Limited (IMMP)? Join Class Action Suit Seeking Recovery - Contact SueWallSt
Press releaseMay 20, 6:05 PM ETGlobe Newswire
IMMUTEP CLASS ACTION LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Immutep Ltd. and Encourages Investors to Contact the Firm
Press releaseMay 20, 9:00 AM ETPRNewswire
IMMP Deadline Alert: Levi & Korsinsky Reminds Immutep Limited (IMMP) Investors of Securities Class Action Deadline on July 6, 2026
Press releaseMay 19, 7:55 PM ETPRNewswire
IMMP Investors Have Opportunity to Lead Immutep Ltd. Securities Fraud Lawsuit
NewsApr 15, 1:25 PM ETAvi Kapoor
Nasdaq Surges 200 Points; Morgan Stanley Posts Upbeat Earnings
NewsApr 15, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsApr 15, 12:40 PM ETVandana Singh
Immutep Gets FDA Boost For Lead Cancer Drug, Stock Doubles
NewsApr 15, 9:48 AM ETAvi Kapoor
Dow Gains 100 Points; Bank of America Earnings Top Views
NewsMar 13, 1:06 PM ET
12 Health Care Stocks Moving In Friday's Intraday Session
NewsMar 13, 1:01 PM ETAvi Kapoor
Crude Oil Gains Over 1%; VEON Shares Spike Higher
NewsMar 13, 9:44 AM ETAvi Kapoor
Dow Gains Over 300 Points; US GDP Growth Revised Lower In Q4
NewsMar 13, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsNov 13, 4:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsMay 21, 5:06 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsMay 15, 3:50 PM ETVandana Singh
Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Immutep Announces Presentation of Quality of Life Data from EFTISARC-NEO Phase II Trial at ESMO 2026

Immutep Announces Late-Breaking Abstract on IMP761 Accepted for Poster Presentation at ACR Convergence 2026

Immutep Regains Compliance with Nasdaq Minimum Bid Price Requirement

Immutep Receives ~A$0.86 Million R&D Tax Incentive

Change to American Depositary Share Ratio

Immutep Outlines Focused Development Strategy for Eftilagimod Alfa (“efti”)

Immutep Announces Abstract Accepted for Presentation at the European Society for Medical Oncology (ESMO) Congress 2026

Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor

Immutep Provides Clinical Update in 1st line NSCLC: Positive Mature Overall Survival Data from INSIGHT-003 and Update from TACTI-004

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines – IMMP

Robbins LLP Urges IMMP Stockholders to Move for Lead Plaintiff Before the July 6, 2026 Deadline

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines – IMMP

Portnoy Law Firm Announces Class Action on Behalf of Immutep Limited Investors

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines - IMMP

IMMP Deadline Alert: Levi & Korsinsky Reminds Immutep Limited (IMMP) Investors of Securities Class Action Deadline on July 6, 2026

IMMP Investor Alert - Immutep Limited Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

Robbins LLP Reminds IMMP Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Immutep Limited

IMMP Shareholder Alert: Immutep Limited Securities Class Action Lawsuit - Investors Should Contact SueWallSt

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines - IMMP

IMMP DEADLINE: Levi & Korsinsky Reminds Immutep Limited Investors of Upcoming Securities Class Action Deadline

Immutep Limited Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - IMMP

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Immutep Limited of Class Action Lawsuit and Upcoming Deadlines – IMMP

IMMP Shareholder Alert: Immutep Limited Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

IMMP Shareholder Alert: Immutep Limited Securities Class Action Lawsuit - Investors With Losses May Contact The Gross Law Firm

IMMP Investors Have Opportunity to Lead Immutep Limited Securities Fraud Lawsuit with the Schall Law Firm

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 6, 2026 in Immutep Limited Lawsuit - IMMP

SueWallSt Reminds Immutep Limited Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of July 6, 2026 - IMMP

IMMP Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Immutep Limited Securities Lawsuit - Contact Levi & Korsinsky

Immutep Limited Class Action Reminder - Robbins LLP Encourages IMMP Investors to Contact the Firm for Information About Their Rights

IMMP Shareholder Alert: July 6, 2026 Lead Plaintiff Deadline in Immutep Limited Securities Class Action - Contact The Gross Law Firm

Lost Money on Immutep Limited (IMMP)? Join Class Action Suit Seeking Recovery - Contact SueWallSt

IMMUTEP CLASS ACTION LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Immutep Ltd. and Encourages Investors to Contact the Firm

IMMP Deadline Alert: Levi & Korsinsky Reminds Immutep Limited (IMMP) Investors of Securities Class Action Deadline on July 6, 2026

IMMP Investors Have Opportunity to Lead Immutep Ltd. Securities Fraud Lawsuit

Nasdaq Surges 200 Points; Morgan Stanley Posts Upbeat Earnings

12 Health Care Stocks Moving In Wednesday's Intraday Session

Immutep Gets FDA Boost For Lead Cancer Drug, Stock Doubles

Dow Gains 100 Points; Bank of America Earnings Top Views

12 Health Care Stocks Moving In Friday's Intraday Session

Crude Oil Gains Over 1%; VEON Shares Spike Higher

Dow Gains Over 300 Points; US GDP Growth Revised Lower In Q4

12 Health Care Stocks Moving In Friday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

Immutep Reports 61% Response Rate In Lung Cancer Trial With Keytruda-Based Triple Combo